Cadence Biomedical specializes in developing innovative neurorehabilitation and physical therapy devices aimed at restoring walking ability for individuals affected by stroke, spinal cord injuries, and other neurological conditions such as multiple sclerosis. Their flagship product, Kickstart, is a wearable walking device that provides active step assistance without the use of electronic stimulation. It stabilizes the hip and leg while using its proprietary Exotendon technology to gently lift and move the leg through a safe, guided, and proper step. This technology is designed to help users re-learn natural, reflexive walking, offering stability, control, and assistance in regaining their ability to walk.

Cadence Biomedical primarily serves patients undergoing physical therapy and neurorehabilitation, including veterans and individuals with chronic neurological conditions. The company operates in the medical device market, focusing on rehabilitation technologies. Their business model involves selling the Kickstart device to rehabilitation centers, hospitals, and directly to consumers. Revenue is generated through the sale of the device and potentially through partnerships with healthcare providers.

Keywords: neurorehabilitation, physical therapy, stroke recovery, spinal cord injury, wearable device, Exotendon technology, walking assistance, rehabilitation technology, medical device, multiple sclerosis.